Sinocare
Clinical trials sponsored by Sinocare, explained in plain language.
A Chinese medical device company specializing in blood glucose monitoring systems.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Can a wearable sensor beat Finger-Prick tests for type 2 diabetes?
Disease control OngoingThis trial asks whether real-time continuous glucose monitoring (CGM) can improve blood sugar control in adults with type 2 diabetes who do not use insulin. Participants will either use a CGM device or stick to standard self-monitoring with a blood glucose meter. The study tracks…
Sponsor: Sinocare • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New CGM device aims to simplify diabetes management
Disease control By invitation onlyThis study is testing a new continuous glucose monitor (CGM) called the iCan o3 in 70 adults with type 1 or type 2 diabetes. Participants will wear the device for 60 days to see if it improves their blood sugar control, especially the time spent in a healthy range. The goal is to…
Sponsor: Sinocare • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC